dilluns, 26 d’octubre del 2015

Nextremity picks up Del Palma Orthopedics foot fusion assets

Nextremity SolutionsFoot and ankle implant developer Nextremity Solutions said last week it completed its acquisition of Del Palma Orthopedic‘s foot fusion technology assets

The purchase consists of multiple issued and in-prosecution utility and design patents and their associated intellectual property, as well as partially developed foot fusion devices, Warsaw, Ind.-based Nextremity Solutions said.

“The acquisition of the Del Palma technology is another step in Nextremity’s journey to being recognized as the leader in innovation within the foot and ankle market.  Given the interest in this technology by others in the foot and ankle marketplace, Nextremity is excited about obtaining this IP and the opportunity to bring this technology to foot and ankle surgeons in order to improve their patient outcomes,” Nextremity CFO Frank Patton said in prepared remarks.

Nextremity plans to launch the assets it purchased from Columbia City, Ind.-based Del Palma Orthopedics in the next 12-18 weeks, according to a press release.

The company said the purchase would both expand its product offerings and have other applications within different market segments.

“Del Palma along with key influential surgeons had a vision for a unique system to treat certain conditions in the foot, ankle, hand, and wrist; a system that lowers inventory requirements and increases procedural repeatability that provides for better outcomes.  We are excited to find the right partner in Nextremity Solutions to finish the development and commercialization of the system.  It a privilege to work with partners where goals are aligned; to provide better outcomes for patients and surgeons,” DPO CFO Brian More said in a press release.

In January, Nextremity Solutions said it hired OrthoPediatrics founder Nick Deeter to be chairman & CEO.

The post Nextremity picks up Del Palma Orthopedics foot fusion assets appeared first on MassDevice.



from MassDevice http://ift.tt/1NwDTtg

Cap comentari:

Publica un comentari a l'entrada